HMGB1 and neoplasm: Subgroup analysis was also performed by the type of malignancy and ethnicity stratification in the current study, however, no obvious differences were found in the tumour risks in the HMGB1 rs1045411 polymorphism amongst the cancer types except for breast cancer and hepatocellular carcinoma.